Skip to main content

Forum on Drug Discovery, Development, and Translation 2019 Annual Report (2020) / Chapter Skim
Currently Skimming:

Reflecting Back: Forum Activities in 2019
Pages 6-9

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 6...
... Workshops and Meetings Updating Labels for Generic Oncology Drugs: A Meeting The Forum, in collaboration with the National Academies' National Cancer Policy Forum, hosted a public meeting, sponsored by FDA, on March 26, 2019, that convened expert stakeholders to discuss the challenges and opportunities for updating labels for generic oncology drugs. The meeting featured discussions about current regulatory requirements for labeling updates, review processes for clinical practice guidelines for oncology, and how outdated drug labeling can impact clinical care.
Read the entire page →
From page 7...
... Enhancing Scientific Reproducibility Through Transparent Reporting: A Workshop In collaboration with the National Academies' Forum on Neuroscience and Nervous System Disorders, National Cancer Policy Forum, and Roundtable on Genomics and Precision Health, the Forum convened a workshop on September 25–26, 2019, to examine the current state of transparency in reporting biomedical research (e.g., disclosure of the availability and location of data, materials, analysis, and methodology) and to explore the possibility of improving the harmonization of guidelines across journals and funding agencies so that biomedical researchers propose and report data in a consistent manner.
Read the entire page →
From page 8...
... Sharing Clinical Trial Data: Challenges and a Way Forward: A Workshop In collaboration with the National Academies' Forum on Neuroscience and Nervous System Disorders, National Cancer Policy Forum, and Roundtable on Genomics and Precision Health, the Forum hosted a public workshop to examine the progress and remaining gaps in clinical trial data sharing following the publication of the 2015 Institute of Medicine (IOM) report Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk.
Read the entire page →
From page 9...
... Reflecting Back: Forum Activities in 2019 Participants discuss actions stakeholders could take to improve transparent reporting of biomedical research during a 2019 workshop on Enhancing Scientific Reproducibility Through Transparent Reporting.
Read the entire page →

Key Terms

  • sharing clinical
  • transparent reporting
  • cancer policy
  • policy forum
  • reporting biomedical

  • trial data
  • labeling updates
  • generic oncology
  • enhancing scientific
  • scientific reproducibility

  • updating labels
  • including clinical
  • forum holds
  • drug labeling
  • forum convene

  • outdated drug
  • clinical trialists
  • biomedical researchers
  • report sharing
  • drug development

  • precision health
  • research lifecycle
  • sharing following
  • participants discussed
  • oncology drugs

  • meeting participants
  • reporting throughout
  • patient populations
  • including indications
  • key stakeholders


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.